Abstract
The cell-surface RAGE [receptor for AGE (advanced glycation end-products)] is associated with the development of diabetic vascular complications, neurodegenerative disorders and inflammation. Recently, we isolated a human RAGE splice variant, which can work as a decoy receptor for RAGE ligands, and named it esRAGE (endogenous secretory RAGE). In the present study, we have isolated the murine equivalent of esRAGE from brain polysomal poly(A)+ (polyadenylated) RNA by RT (reverse transcription)-PCR cloning. The mRNA was generated by alternative splicing, and it encoded a 334-amino-acid protein with a signal sequence, but lacking the transmembrane domain. A transfection experiment revealed that the mRNA was actually translated as deduced to yield the secretory protein working as a decoy in AGE-induced NF-kappaB (nuclear factor kappaB) activation. RT-PCR and immunoblotting detected esRAGE mRNA and protein in the brain, lung, kidney and small intestine of wild-type mice, but not of RAGE-null mice. The esRAGE expression was increased in the kidney of diabetic wild-type mice. The present study has thus provided an animal orthologue of esRAGE for clarification of its roles in health and disease.
MeSH Terms
Alternative Splicing
Amino Acid Sequence
Animals
Blotting, Western
COS Cells
Cell Line, Tumor
Chlorocebus aethiops
Diabetes Mellitus, Experimental/metabolism
Glioma/pathology
Glycation End Products, Advanced/metabolism
Humans
Intestine, Small/metabolism
Kidney/metabolism
Ligands
Lung/metabolism
Male
Mice
Mice, Inbred C57BL
Molecular Sequence Data
NF-kappa B/metabolism
Nerve Tissue Proteins/analysis
Organ Specificity
RNA, Messenger/genetics
Rats
Receptor for Advanced Glycation End Products
Receptors, Immunologic/analysis,deficiency,genetics,metabolism
Reverse Transcriptase Polymerase Chain Reaction
Sequence Alignment
Sequence Homology, Amino Acid
Solubility
Species Specificity
Structure-Activity Relationship
Surface Plasmon Resonance
Transfection
Chemicals
Glycation End Products, Advanced
Ligands
NF-kappa B
Nerve Tissue Proteins
RNA, Messenger
Receptor for Advanced Glycation End Products
Receptors, Immunologic
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Harashima Ai
Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8640, Japan.
Yamamoto Yasuhiko
Cheng Chunmei
Tsuneyama Koichi
Myint Khin Mar
Takeuchi Akihiko
Yoshimura Kazunobu
Li Hui
Watanabe Takuo
Takasawa Shin
Okamoto Hiroshi
Yonekura Hideto
Yamamoto Hiroshi
References (18)
18 references, click to expand
-
Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs.
Mod Pathol. 2005 Oct;18(10):1385-96
PMID: 15933755
-
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.
J Clin Invest. 2005 May;115(5):1267-74
PMID: 15841214
-
Development of an ELISA for esRAGE and its application to type 1 diabetic patients.
Diabetes Res Clin Pract. 2006 Aug;73(2):158-65
PMID: 16488505
-
RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.
Trends Endocrinol Metab. 2000 Nov;11(9):368-75
PMID: 11042467
-
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
J Clin Invest. 2001 Jul;108(2):261-8
PMID: 11457879
-
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Biochem J. 2003 Mar 15;370(Pt 3):1097-109
PMID: 12495433
-
Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
J Am Soc Nephrol. 2003 May;14(5):1383-95
PMID: 12707408
-
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.
J Exp Med. 2003 Nov 17;198(10):1507-15
PMID: 14623906
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem. 1976 May 7;72:248-54
PMID: 942051
-
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
J Biol Chem. 1992 Jul 25;267(21):14998-5004
PMID: 1378843
-
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.
J Biol Chem. 1994 Apr 1;269(13):9889-97
PMID: 8144582
-
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
J Biol Chem. 1995 Oct 27;270(43):25752-61
PMID: 7592757
-
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
Nature. 1996 Aug 22;382(6593):685-91
PMID: 8751438
-
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.
Nat Med. 1998 Sep;4(9):1025-31
PMID: 9734395
-
Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
J Biol Chem. 1999 Jul 9;274(28):19919-24
PMID: 10391939
-
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.
Cell. 1999 Jun 25;97(7):889-901
PMID: 10399917
-
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
J Biol Chem. 2004 Nov 26;279(48):50019-24
PMID: 15381690
-
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2587-93
PMID: 16224056